本文選題：中性粒細胞　切入點：淋巴細胞　出處：《重慶醫(yī)科大學》2017年碩士論文

【摘要】：目的:中性粒細胞淋巴細胞比值(neutrophil-to-lymphocyte ratio,NLR)是一個新的炎癥指標,臨床上可預測疾病的預后。炎癥反應在乙肝病毒感染者病情加重的過程中起著重要的作用,本文就NLR在預測其病情演變中的作用進行了初步的研究。方法:總共收集了349例研究對象的資料,其中包括體檢中心的健康人60例(A組),慢性乙型肝炎重度111例(B組),乙肝肝硬化失代償期92例(C組),慢加急性肝衰竭(acute-on-chronic liver failure,ACLF)86例(D組)。收集患者的血常規(guī),肝功能,凝血功能結(jié)果,計算其NLR。根據(jù)病情進展情況將B組分為B1組(16例,進展為ACLF)和B2組(95例,未進展為ACLF)。分析各組間NLR值的差異,并進行預后的預測分析。采用SPSS 20.0統(tǒng)計分析軟件進行組間比較、相關(guān)性等統(tǒng)計分析,以P0.05為差異有統(tǒng)計學意義。結(jié)果:(1)A、B、C、D組NLR值分別為2.22(1.76,3.05),2.54(1.78,3.49),3.07(1.95,5.04),3.41(2.01,5.15)。隨著病情的加重,NLR值逐漸增加。(2)B組中有16例進展為ACLF(B1組),95例仍為慢性乙型肝炎重度(B2組),通過單因素和多因素回歸分析得出,NLR和PTA是影響疾病進展的預后因素。比較B1組和B2組入組時的NLR,差異有統(tǒng)計學意義(3.97±1.54VS2.71±1.54,P=0.004)。16例慢性乙型肝炎重度患者進展為ACLF時,其對應的NLR是明顯增加的(P0.05)。通過ROC曲線分析,慢性乙型病毒性肝炎重度進展成ACLF的cut-off值為2.79(AUC:0.739,P=0.002)。(3)NLR預測患者為終末期肝病(end-stage liver disease,ESLD)的cut-off值為3.94(AUC:0.612,P=0.001)。(4)相關(guān)性分析顯示NLR與PTA、ALB呈負相關(guān)(P0.001),但與TB則呈正相關(guān)。結(jié)論:外周血NLR可以反映病情進展,并預測肝衰竭的發(fā)生。
[Abstract]:Objective: neutrophil-to-lymphocyte ratio (neutrophil-to-lymphocyte) is a new inflammatory marker, which can predict the prognosis of the disease clinically. Inflammatory reaction plays an important role in the process of exacerbation of hepatitis B virus infection. This paper makes a preliminary study on the role of NLR in predicting the development of its disease. Methods: a total of 349 cases were collected. There were 60 healthy persons in the physical examination center, 111 patients with severe chronic hepatitis B, 92 patients with decompensated hepatitis B and 86 patients with acute liver failure. Blood routine examination and liver function were collected. According to the progress of the disease, group B was divided into group B1 (n = 16) and group B2 (n = 95). SPSS 20.0 statistical analysis software was used to carry out the statistical analysis of inter-group comparison, correlation and so on. Results the NLR value of group D was 2.22 / 1.766 / 3.05 and 2.54 / 1.83.49 / 3.071.955.04 / 3.41 / 2.41 / 2. 01 / 2.15 respectively. With the exacerbation of the disease, 16 cases in group B developed into ACLF(B1 group, 95 cases were still chronic hepatitis B / B group (n = 95), through univariate and multifactorial factors. The regression analysis showed that NLR and PTA were the prognostic factors influencing the progression of chronic hepatitis B. the difference between group B1 and group B2 was statistically significant (3.97 鹵1.54VS2.71 鹵1.54). 16 patients with severe chronic hepatitis B had progression to ACLF. The corresponding NLR is a significant increase of P0. 05%. The ROC curve analysis shows that. The cut-off value of ACLF in patients with severe progression of chronic hepatitis B to ACLF was 2.79% AUC: 0.739p 0.739p 0.002nLR for predicting end-stage liver disease of patients with end-stage liver disease (cut-off = 3.94 AUC: 0.612P 0.001n.4.) correlation analysis showed that NLR was negatively correlated with ACLF, but positively correlated with TB. Conclusion: peripheral blood NLR can be negatively correlated with NLR and TB. Conclusion: peripheral blood NLR can be positively correlated with PTA-ALB. Conclusion: peripheral blood NLR can be negatively correlated with PTA-ALB. Conclusion: peripheral blood NLR can be positively correlated with NLR, but it is positively correlated with TB.Conclusion: peripheral blood NLR can be positively correlated with NLR. To reflect the progress of the disease, The occurrence of liver failure was predicted.
【學位授予單位】：重慶醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R512.62

【參考文獻】

相關(guān)期刊論文 前10條

1 Hao-Jie Yang;Zhe Guo;Yu-Ting Yang;Jing-Hang Jiang;Ya-Peng Qi;Ji-Jia Li;Le-Qun Li;Bang-De Xiang;;Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis[J];World Journal of Gastroenterology;2016年21期

2 張輝艷;謝桂娟;陳晴;趙博;毛青;張緒清;;乙型肝炎病毒相關(guān)慢加急性肝衰竭前期的診斷標準探討[J];中華肝臟病雜志;2016年05期

3 李元元;耿華;于雙杰;張政;呂颯;陳黎明;王福生;;中性粒細胞與淋巴細胞比值與乙型肝炎相關(guān)性慢加急性肝衰竭疾病進展的臨床研究[J];胃腸病學和肝病學雜志;2016年04期

4 王貴強;王福生;成軍;任紅;莊輝;孫劍;李蘭娟;李杰;孟慶華;趙景民;段鐘平;侯金林;賈繼東;唐紅;盛吉芳;彭R，

本文編號：1674974